About Patrick Enright
Patrick Enright is a director and 10% owner at Jazz Pharmaceuticals plc.
Form D filings name Patrick Enright as a director at Zenas BioPharma, BioAge Labs and Rivus Pharmaceuticals.
Patrick Enright reports to the SEC as a director or major shareholder of 24 public companies, including Zenas BioPharma (ZBIO), BioAge Labs (BIOA) and Vera Therapeutics (VERA).
Patrick Enright first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Patrick Enright in the role, so the role may have started earlier or lasted longer.
JP
Jazz Pharmaceuticals plc
Director and 10% owner
2009 – 2026 · Public company (JAZZ)
VI
Vera Therapeutics, Inc.
Director and 10% owner
2021 – 2026 · Public company (VERA)
RI
Rapid Micro Biosystems, Inc.
10% owner
2021 – 2026 · Public company (RPID)
VI
LI
Lexeo Therapeutics, Inc.
10% owner
2023 · Public company (LXEO)
AI
Aptinyx Inc.
Director and 10% owner
2018 – 2022 · Public company (APTX)
SI
Sierra Oncology, Inc.
10% owner
2019 – 2022 · Public company (SRRA)
II
Inozyme Pharma, Inc.
10% owner
2020 – 2022 · Public company (INZY)
TI
Tourmaline Bio, Inc.
10% owner
2021 · Public company (TRML)
EI
Eargo, Inc.
10% owner
2020 – 2021 · Public company (EAR)
8I
89bio, Inc.
10% owner
2019 – 2020 · Public company (ETNB)
AI
Aimmune Therapeutics, Inc.
Director and 10% owner
2015 – 2020 · Public company (AIMT)
MI
Molecular Templates, Inc.
Director and 10% owner
2006 – 2020 · Public company (MTEM)
VI
Vaxcyte, Inc.
10% owner
2020 · Public company (PCVX)
VI
Venus Concept Inc.
10% owner
2019 · Public company (VERO)
AI
Axonics, Inc.
10% owner
2018 · Public company (AXNX)
TI
Tricida, Inc.
10% owner
2018 · Public company (TCDA)
CI
Collegium Pharmaceutical, Inc.
10% owner
2015 – 2017 · Public company (COLL)
KI
Kala Bio, Inc.
10% owner
2017 · Public company (KALA)
CI
Corcept Therapeutics Inc.
Director and 10% owner
2008 – 2017 · Public company (CORT)
EI
Esperion Therapeutics, Inc.
Director and 10% owner
2013 – 2015 · Public company (ESPR)
SI
Sequenom Inc.
Director
2006 – 2007 · Public company (SQNM)
Key Colleagues at Startups
The people Patrick Enright works with at each company, as listed on that company's latest Form D.
Zenas BioPharma, Inc. · Form D, May 14, 2024
TK
Tomas Kiselak
Director
PA
Patricia Allen
Director
JF
Joseph Farmer
PRESIDENT and CHIEF OPERATING OFFICER
LJ
Leon Moulder, Jr.
Executive officer and director
JN
Jake Nunn
Director
TX
Tim Xiao
Director
JF
Jennifer Fox
Executive officer
JB
James Boylan
Director
TF
Tanya Fischer
Executive officer
JO
John Orloff
Director
HL
Hongbo Lu
Director
BioAge Labs, Inc. · Form D, Feb 13, 2024
EM
Eric Morgen
Director
DG
Dov Goldstein
Executive officer
JC
Jason Coloma
Director
KF
Kristen Fortney
CEO and director
VP
Vijay Pande
Director
RH
Rehka Hemrajani
Director
JH
James Healy
Director
Rivus Pharmaceuticals, Inc. · Form D, Oct 4, 2021
SK
Shaharyar Khan
Executive officer and director
JD
Jayson Dallas
Director
AC
Allen Cunningham
Chief Executive Officer and director
FR
Francesco De Rubertis
Director